Welcome to our dedicated page for Gevo SEC filings (Ticker: GEVO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Gevo, Inc. (GEVO) SEC filings page brings together the company’s regulatory disclosures, including Form 8-K current reports, that describe material events affecting this renewable fuels, chemicals, and carbon management business. These filings provide detail on topics such as executive leadership changes, amendments to corporate bylaws, project financing, carbon credit sales agreements, and tax credit transfer arrangements tied to ethanol and renewable natural gas production.
Through its filings, Gevo outlines how it monetizes Section 45Z Clean Fuel Production Credits generated from ethanol volumes at its North Dakota facility, including tax credit transfer agreements with financial institutions and banks. Other 8-Ks describe bond financing agreements used to refinance revenue bonds for its dairy-based renewable natural gas project in Iowa, as well as carbon dioxide removal sales agreements with counterparties like Biorecro North America, LLC for credits associated with its carbon capture and sequestration facilities.
Investors can use annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) to review segment information related to ethanol, renewable natural gas, and carbon activities, along with risk factors and management’s discussion and analysis. Current reports on Form 8-K capture governance developments such as the appointment of a new president who is expected to become chief executive officer, the adoption of third amended and restated bylaws, and other corporate actions.
On Stock Titan, these filings are complemented by AI-powered summaries that highlight key points from lengthy documents, helping readers understand complex items like tax credit transfer structures, carbon dioxide removal contracts, and project financing terms. Real-time updates from EDGAR ensure that new GEVO filings, including Forms 10-K, 10-Q, and 4 (insider transaction reports), are accessible as they are posted. This combination of primary documents and AI explanations can save time for users who want to track how Gevo structures its low-carbon fuel, RNG, and carbon credit businesses through formal SEC disclosures.
Gevo (GEVO) director reports Form 4 insider transactions. On 10/14/2025, the insider exercised stock options for 100,000 shares at $0.67 (Code M) and sold 100,000 common shares at a weighted average price of $2.5027 (Code S) pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2024.
Following these transactions, the insider directly beneficially owned 2,942 common shares. Derivative holdings reported as beneficially owned after the transactions were 24,639 stock options.
Gevo (GEVO) reported an insider transaction by its President & COO. On October 15, 2025, the officer sold 100,000 shares of common stock at a weighted average price of $2.8187 per share, executed under a Rule 10b5-1 trading plan adopted on November 26, 2024.
Following the sale, the officer beneficially owns 1,531,938 shares directly and 22,008.08 shares indirectly through a 401(k) plan. The filing notes that 8.60 shares were disposed between September 4, 2025 and October 15, 2025 from the 401(k) to cover administrative fees.
Gevo (GEVO) announced that the U.S. Department of Energy’s Loan Programs Office extended its conditional commitment to guarantee a
The extension allows Gevo and the DOE LPO to evaluate potential project-scope changes aligned with energy policies and priorities. Options under review include building a lower-cost ATJ-30 facility targeting 30 million gallons per year of jet fuel at Gevo’s existing ethanol and carbon capture site in North Dakota, and optimizing the use of captured CO2 for enhanced oil recovery.
Andrew Shafer, Chief Customer, Marketing & Brand Officer at Gevo (GEVO), reported insider sales under a pre-established trading plan. On 09/22/2025 he disposed of 5,000 shares of Gevo common stock at a weighted-average price of $2.0124 per share, with the sales executed pursuant to a 10b5-1 plan adopted on November 22, 2024. Following the reported transactions, the filing shows the reporting person beneficially owned 320,620 shares directly and an additional 9,803.21 shares indirectly through a 401(k) plan. The filing notes that 3.71 shares were disposed under the 401(k) to cover administrative fees between 08/20/2025 and 09/22/2025.
Paul D. Bloom, Chief Business Officer of Gevo, Inc. (GEVO), reported a transaction on 09/17/2025 selling 75,000 shares of common stock to cover tax withholding on vested restricted stock. The sales were effected under a 10b5-1 trading plan adopted November 21, 2024, at a weighted-average price of $2.0058 per share, with individual sale prices ranging from $2.00 to $2.03. After the disposition, Mr. Bloom beneficially owns 923,591 shares directly and 22,039.17 shares indirectly through a 401(k) plan. The filing discloses the routine nature of the sale and offers availability of detailed per-price sale information on request.
Gevo, Inc. filed an 8-K disclosing a Carbon Dioxide Removal Sales Agreement dated September 18, 2025 between Net‑Zero Richardton, LLC and Biorecro North America, LLC. The filing appears as a material event notice and includes cover page information and an interactive data reference. The document identifies Gevo's principal office in Englewood, CO and lists an officer signature by E. Cabell Massey, Vice President, Legal and Corporate Secretary. The filing provides the existence and counterparties of the agreement but does not disclose contract value, volumes, pricing, delivery schedule, or other commercial or financial terms, so material economic impact cannot be assessed from the text provided.
Form 144 notice for Gevo, Inc. (GEVO) indicates a proposed sale of 225,000 shares of common stock through Stifel Nicolaus & Company, with an aggregate market value of $451,305.00. The shares are scheduled for sale approximately on 09/17/2025 on the Nasdaq. The filing states the securities were acquired as Restricted Stock Units on 08/20/2021 from the issuer, totaling 392,175 shares acquired on that date and with cash payment noted.
The filing also discloses recent sales by the same person, Paul Bloom, totaling several transactions in August and September 2025 (largest single prior sale listed: 33,073 shares on 08/05/2025). The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
Gevo, Inc. filed a current report to notify investors that it has posted a revised investor presentation on its website at investors.gevo.com. The updated materials, dated September 9, 2025, are also furnished as Exhibit 99.1 to this report, giving shareholders a consolidated source of the latest company information and outlook.
The company notes that the investor presentation and related disclosure under Item 7.01 are being furnished rather than filed, meaning they are not subject to certain liability provisions of the Exchange Act and are not automatically incorporated into other Securities Act or Exchange Act filings unless specifically referenced.
Kimberly T. Bowron, Chief People and IT Officer of Gevo, Inc. (GEVO), reported insider share dispositions on 09/04/2025. She sold 1,530 shares of Gevo common stock to cover tax withholding from a restricted stock vesting, with a weighted average sale price of $1.6295 (sales ranged from $1.61 to $1.64). The sales were effected pursuant to a 10b5-1 trading plan adopted December 2, 2024. After the reported sale, Bowron beneficially owns 481,226 shares directly and holds 7,864.35 shares indirectly through the company 401(k) plan. The report also discloses that between August 5, 2025 and September 4, 2025 the reporting person disposed of 2.99 shares under the 401(k) plan to cover administrative fees. The Form 4 was signed by attorney-in-fact E. Cabell Massey on 09/05/2025.
Agiri Oluwagbemileke Yusuf, Chief Financial Officer of Gevo, Inc. (GEVO), reported sales and plan-related disposals in a Form 4 filing. On 09/04/2025 the reporting person sold 1,731 shares of GEVO common stock to satisfy tax withholding obligations arising from the vesting of a restricted stock award; the sales were made under a 10b5-1 trading plan adopted on 11/22/2024 at a weighted average price of $1.6295 per share (individual trade prices ranged from $1.61 to $1.64). After the reported sale the reporting person beneficially owned 276,104 shares directly and held 18,970.28 shares indirectly through a 401(k) plan. Separately, between 08/20/2025 and 09/04/2025 the reporting person disposed of 7.29 shares under the issuer's 401(k) plan to cover administrative fees. The Form 4 was signed by an attorney-in-fact on 09/05/2025.
FAQ
What is the current stock price of Gevo (GEVO)?
What is the market cap of Gevo (GEVO)?
